Translational Development Acquisition TDAC
NASDAQ TDAC
$10.85 +0.01 (+0.05%)
As of: Aug 21, 2026 · 3:58 PM EDT

Translational Development Acquisition (TDAC) Shares Outstanding (Entity) (2023 - 2026)

Translational Development Acquisition (TDAC) Shares Outstanding (Entity) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 56.93 Mn
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 51.75 Mn
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 50.00 Mn
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 45.00 Mn
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 35.94 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 36.74 Mn
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 37.50 Mn
8 Gores Holdings X 385.06 Mn 384.87 Mn - 36.11 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 32.92 Mn
10 Translational Development Acquisition 182.66 Mn 182.57 Mn - 16.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 17.25 Mn
Dec 31, 2025 17.25 Mn
Sep 30, 2025 17.25 Mn
Jun 30, 2025 17.25 Mn
Mar 31, 2025 17.25 Mn
Dec 31, 2024 4.66 Mn
Sep 30, 2024 4.66 Mn
Dec 31, 2023 4.66 Mn